ArticleLiver international : official journal of the International Association for the Study of the Liver2022
Outcomes of atezolizumab and bevacizumab for hepatocellular carcinoma: Does age matter?
Wei-Yu Kao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.